Virtual West Oncology Conference


 

ASH Updates on Lymphomas: Bispecific Antibodies for Patients Who Relapse After CAR-T or ASCT, CAR-T & Bispecific Antibodies for Indolent Lymphomas

108 views
March 8, 2021
0 Comments
Login to view comments. Click here to Login